
Selling a Healthcare Services Business?
Healthcare services businesses operate in a landscape shaped by regulation, reimbursement, and relationships. Buyers evaluate these companies differently than they evaluate businesses in other industries, because the risks are different: licensing, credentialing, payor mix, compliance history, referral networks, and provider retention all carry weight that doesn't exist in a standard commercial transaction.
HartmannRhodes works with owners of established healthcare services companies who are preparing for a confidential, well-managed sale. Whether you're a founder looking toward retirement, a physician planning a transition, or a multi-location operator evaluating your options, understanding how healthcare buyers assess value gives you more control over the process and the outcome.
How Buyers Assess a Healthcare Services Business
A buyer isn't purchasing your patient census, your office space, or your brand. The buyer is trying to determine whether the business will continue generating dependable revenue under new ownership, inside a regulated environment, with the clinical team and referral relationships intact.
For healthcare services companies, that assessment typically centers on four things:
A payor mix that supports the valuation.
Revenue in healthcare isn't just about volume. It's about who's paying, how much, and how reliably. Buyers will break down revenue by payor class and evaluate each one differently.
They will examine:
-
Revenue by payor: Medicare, Medicaid, commercial insurance, managed care, private pay
-
Reimbursement rates and trends by payor
-
Contract terms with commercial payors and managed care organizations
-
Revenue concentration across payor types
-
Claims denial rates, aging, and collection patterns
-
Sensitivity to reimbursement rate changes or policy shifts
​
A diversified payor mix with strong commercial and private-pay components typically supports a higher valuation. Heavy dependence on government payors introduces reimbursement risk that buyers will factor into their offer.
Providers who stay.
Healthcare businesses are built around the people who deliver care. Losing key providers after a sale can mean losing patients, referral sources, and revenue. Buyers know this, and provider retention is one of the first things they evaluate.
They will assess:
-
Provider tenure, compensation, and employment agreements
-
Non-compete and non-solicitation provisions
-
Credentialing and licensing tied to individuals vs. the entity
-
Provider productivity and patient volume by provider
-
Recruitment pipeline and the local labor market
-
Whether clinical leadership depends on a single individual
​
A deep, stable clinical team with documented employment agreements and clear succession coverage gives buyers confidence. A practice that depends on one or two providers for the majority of its revenue creates risk that will show up in the deal structure.
Compliance that holds up under diligence.
Regulatory compliance in healthcare isn't a checkbox. It's a deal requirement. Buyers, especially those backed by private equity or operating as part of a larger platform, will conduct thorough compliance diligence. Issues that surface during that process can delay, restructure, or kill a transaction.
They will evaluate:
-
HIPAA policies, training, and breach history
-
State licensing, accreditation, and certification status
-
Medicare and Medicaid conditions of participation
-
Billing practices and coding accuracy
-
Compliance program documentation and training records
-
Any history of audits, investigations, or corrective action plans
​
A well-documented compliance program signals that the business takes regulatory requirements seriously and reduces the buyer's perceived risk. Gaps in documentation, training lapses, or unresolved audit findings create problems that are difficult to explain away during diligence.
​
A practice that runs beyond the founder.
Many healthcare businesses were built by a single clinician, physician, or entrepreneur who still serves as the clinical anchor, the referral magnet, and the operational decision-maker. That involvement may be why the practice thrives, but it also creates transition risk.
They will evaluate:
-
How deeply the founder is involved in clinical care, operations, and referral relationships
-
Whether management functions are handled by a dedicated team or by the owner
-
Referral source relationships and who maintains them
-
Brand identity: does the market associate the practice with the company or with the individual?
-
Transition timeline expectations and post-sale involvement requirements
-
Whether the business can maintain volume and quality without the current owner
​
The more the practice operates as a business rather than an extension of the founder, the easier it is to transfer and the stronger the terms it will command.
Where Healthcare Transactions Get Complicated
Healthcare M&A carries a layer of complexity that other industries don't. Licensing requirements, reimbursement structures, credentialing, compliance history, and the regulatory environment all create risks and opportunities that a generalist broker is unlikely to fully appreciate.
Two healthcare businesses with similar revenue can receive very different valuations depending on how these factors hold up:
Payor Mix & Reimbursement Risk
The composition of revenue by payor type is one of the most significant drivers of value in a healthcare transaction. Commercial insurance and private-pay revenue generally commands higher multiples than Medicare or Medicaid, where rates are set by government programs and subject to policy changes outside the owner's control. Buyers will model the revenue under different reimbursement scenarios and stress-test the earnings against rate reductions, payor shifts, and regulatory changes.
Licensing, Credentialing & Regulatory Standing
Healthcare businesses operate under licenses, certifications, and accreditations that may be tied to the entity, to individual providers, or to both. Some licenses transfer with the business. Others require new applications, inspections, or approval periods. Buyers need to understand which is which, because a license that doesn't transfer cleanly can stall or restructure a deal. The same applies to provider credentialing with payors: if the business's ability to bill certain payors depends on a specific provider's credentials, that's a risk tied to an individual, not the company.
Referral Relationships & Revenue Sources
In many healthcare businesses, referral relationships with physicians, hospitals, health systems, and community organizations are a primary driver of patient volume. Buyers will evaluate whether those relationships are institutional (tied to the company's reputation and team) or personal (tied to the owner). They'll also scrutinize referral arrangements for compliance with the Stark Law and Anti-Kickback Statute. Any arrangement that could be characterized as a referral incentive creates regulatory risk that buyers will address before closing.
​
​
Revenue Recognition & Billing Complexity
Healthcare revenue recognition is inherently complex. Contractual adjustments, claims denials, write-offs, capitation payments, cost reports, and timing differences between service delivery and payment all need to be understood and presented clearly. Buyers will test whether reported revenue reflects actual collectible amounts. Reimbursement that looks strong on a gross basis but erodes significantly after adjustments tells a different earnings story than the financials may suggest.
​
Workforce Recruitment & Retention
The healthcare labor market is one of the tightest in any industry. Nurses, therapists, behavioral health professionals, dental hygienists, and support staff are chronically short-supplied in most markets. Buyers will evaluate not only the current team's stability, compensation, and satisfaction, but also the company's ability to recruit and retain going forward. High turnover, unfilled positions, or compensation levels that are significantly below market create operational risk that affects both current performance and future growth.
Clinical Quality & Outcomes
Increasingly, buyers are evaluating clinical quality metrics, patient satisfaction data, and outcomes reporting. In home health and hospice, this includes star ratings and publicly reported quality data. In behavioral health and therapy, it may include treatment completion rates and referral source satisfaction. Strong clinical outcomes support the company's reputation, referral relationships, and ability to negotiate favorable payor contracts. Weak or undocumented quality data raises questions about sustainability.
​
Most of these issues can be identified and addressed well before a transaction begins. Owners who invest in compliance infrastructure, strengthen their clinical teams, diversify their payor mix, and formalize referral relationships enter the market with fewer vulnerabilities and significantly more leverage.
HartmannRhodes helps healthcare services owners understand where their business is strong, where it's exposed, and what can be improved before buyers start asking questions.
The Healthcare Services Companies We Work With
HartmannRhodes works with established, owner-operated healthcare businesses that provide clinical care, therapeutic services, or health-related support. These companies may serve patients directly, contract with health systems and payors, or operate across multiple locations and service lines.
Home Health & Home Care
-
Medicare-certified home health agencies
-
Non-medical home care and personal care companies
-
Private duty nursing agencies
-
Pediatric home health providers
-
Home infusion therapy companies
Hospice & Palliative Care
-
Medicare-certified hospice providers
-
Community-based palliative care programs
-
Hospice inpatient facilities
-
Grief counseling and bereavement services
Behavioral Health & Treatment
-
Outpatient mental health practices
-
Substance abuse and addiction treatment centers
-
Residential treatment facilities
-
Applied behavior analysis (ABA) therapy providers
-
Psychiatric practices and group practices
-
Employee assistance program (EAP) providers
Dental Practices & Groups
-
General dental practices
-
Pediatric dental practices
-
Orthodontic practices
-
Oral surgery practices
-
Multi-location dental groups and DSO affiliates
Physical Therapy & Rehabilitation
-
Outpatient physical therapy clinics
-
Occupational therapy practices
-
Speech-language pathology practices
-
Multi-location rehabilitation groups
-
Sports medicine and orthopedic rehab clinics
Urgent Care & Outpatient Services
-
Urgent care centers
-
Walk-in clinics
-
Ambulatory surgery centers
-
Diagnostic imaging centers
-
Occupational health clinics
-
Infusion therapy centers
Specialty Medical & Physician Practices
-
Dermatology practices and groups
-
Ophthalmology and optometry practices
-
Pain management clinics
-
Gastroenterology practices
-
Cardiology practices
-
Multi-specialty physician groups
Veterinary & Animal Health
-
General veterinary practices
-
Specialty and emergency veterinary hospitals
-
Multi-location veterinary groups
-
Veterinary dental and surgical practices
-
Mobile veterinary services
If your healthcare business isn't listed here, it may still be a strong fit. The most important considerations are whether the business is established, compliant, supported by a capable clinical and operational team, and able to continue delivering care under new ownership.
The Buyers Active in Healthcare
Healthcare services is one of the most actively pursued categories in lower-middle-market M&A. Aging demographics, increasing demand for services, workforce scarcity, and reimbursement complexity have all fueled consolidation, and the pace of acquisition activity continues to accelerate.
Private Equity Platforms
PE firms have been the most aggressive acquirers in healthcare services for more than a decade. They build platforms by acquiring a well-run company, installing professional management, and adding locations and service lines through bolt-on acquisitions. Behavioral health, dental, physical therapy, home health, hospice, veterinary, and urgent care have all seen significant PE platform activity. ​
Health Systems & Hospital Groups
Hospitals and health systems acquire community-based healthcare businesses to extend their continuum of care, capture downstream referrals, and secure provider capacity. A home health agency, outpatient rehab practice, or behavioral health provider that feeds into a system's patient base can carry strategic value well beyond standalone earnings.
Established Healthcare Operators
Larger healthcare companies in the same or adjacent specialties may acquire to expand geography, add capabilities, or increase scale. A multi-location dental group adding practices, a home health company entering a new market, or a behavioral health platform adding a new modality are common examples.
Physician Groups & Clinician Buyers
In some segments, the buyer may be a physician group, a clinician-led investment group, or an experienced healthcare operator looking to step into ownership. These buyers tend to understand the clinical environment and may place higher value on quality, culture, and patient relationships.
The buyer landscape in healthcare is deep but specialized. A well-run process identifies the buyers with the strongest fit, ensures they understand the regulatory and operational nuances of the business, creates competitive tension, and uses that leverage to negotiate the best overall deal.
Managing the Complexities of a Healthcare Services Sale
Healthcare services buyers examine more than financial performance. They look closely at reimbursement exposure, referral sources, licensing, compliance, provider relationships, patient concentration, staffing, documentation, and the owner’s role in the business. Those issues can affect valuation, buyer confidence, and the structure of the transaction.
​
HartmannRhodes helps owners address potential concerns early, present the company clearly, identify buyers who understand the regulatory and operational realities of healthcare, and manage the sale with the discipline needed to protect value and preserve confidentiality.

Confidentiality
Confidentiality carries particular weight in healthcare, where patient trust, referral relationships, staff morale, and regulatory standing can all be affected by a premature disclosure. Referral sources may redirect patients. Key providers may start fielding recruitment calls. Staff may begin looking for stability elsewhere.
HartmannRhodes manages every engagement under strict confidentiality. Buyers sign an NDA and complete a qualification process before receiving any identifying information. The business continues to deliver care and operate normally throughout.
Selling Your Healthcare Services Business:
11 Questions Owners Ask First
1. How are healthcare services businesses valued?
Buyers focus on sustainable earnings, but in healthcare, the composition of those earnings matters as much as the amount. Payor mix is often the single biggest factor: revenue from commercial insurance and private pay typically supports higher multiples than Medicare or Medicaid, where rates are set by government programs and subject to policy changes. Beyond that, buyers evaluate compliance standing, provider retention, referral concentration, licensing and credentialing transferability, clinical quality metrics, and management depth. Two healthcare businesses with similar revenue can attract very different offers depending on who's paying, how defensible the revenue is, and how much regulatory risk the buyer inherits.
2. How does payor mix affect my valuation?
Significantly. Commercial insurance and private-pay revenue are generally valued more highly because rates are negotiable and less vulnerable to government policy changes. Heavy dependence on Medicare or Medicaid introduces reimbursement risk, since those rates can change with little warning and are outside the owner's control. Buyers will model the revenue under different reimbursement scenarios and stress-test the earnings against rate reductions, payor shifts, and regulatory changes. A diversified payor mix with strong commercial and private-pay components reduces the buyer's exposure and typically supports a stronger valuation.
​
3. What is a CHOW, and why does it matter in a healthcare sale?
A CHOW, or Change of Ownership, is the formal process required by CMS to transfer a healthcare provider's Medicare provider agreement and billing privileges to a new owner. The change must be reported within 30 days of the effective date. If the CHOW isn't handled correctly, the buyer's Medicare billing can be suspended, creating a cash flow gap that can last weeks or months. During that gap, the buyer is delivering care and incurring costs but not receiving Medicare payments. A mishandled CHOW can destabilize the business immediately after closing. This is one of the most important regulatory steps in any healthcare transaction, and it needs to be mapped and coordinated well before the closing date.
4. What is an MSO or DSO structure, and will a buyer expect one?
Most states have Corporate Practice of Medicine laws that prohibit non-physician entities from owning a medical practice or employing physicians directly. This means private equity firms and other non-clinician buyers can't simply purchase the clinical entity. Instead, the deal is typically structured through a Management Services Organization (MSO) or, in dental, a Dental Service Organization (DSO). The MSO acquires the non-clinical assets and provides administrative, billing, HR, and operational services under a management services agreement. The clinical entity remains owned by a licensed physician or dentist and retains control over clinical decisions. If you're selling to a PE-backed buyer or a larger platform, this structure will likely be part of the conversation. Understanding how it works before you receive an offer gives you a stronger negotiating position.
5. What happens to my Medicare and Medicaid billing during the transition?
This is one of the most common surprises in healthcare transactions. At closing, the seller stops billing Medicare. The buyer begins delivering care, but Medicare payments are often held in a suspense account until CMS processes the CHOW and issues a tie-in notice confirming the transfer. That process can take weeks, sometimes longer. During that period, the buyer is funding payroll, supplies, and operations without receiving Medicare revenue. If the buyer doesn't have sufficient working capital to absorb that gap, it can create serious financial strain immediately after closing. Both sides need to plan for this, and the purchase agreement should address how the billing transition is handled.
​
6. Does the 36-month rule apply to my business?
If you own a home health agency or hospice, it may. Under 42 CFR 424.550, if a home health agency or hospice undergoes a change in majority ownership within 36 months of its initial Medicare enrollment or its most recent CHOW, the provider agreement does not transfer. CMS created this rule to prevent flipping of Medicare billing numbers. If the rule applies, the buyer would need to enroll as a new provider, go through a state survey, and wait for approval before billing Medicare. Most buyers won't accept that risk. There is a potential exemption if the agency has submitted two consecutive years of full cost reports, but eligibility should be verified with a healthcare regulatory attorney before the business goes to market.
7. How do Stark Law and Anti-Kickback considerations affect the deal?
Buyers will scrutinize any arrangement that involves referrals between related parties. The Stark Law prohibits physicians from referring Medicare or Medicaid patients to entities in which they have a financial relationship, unless a specific exception applies. The Anti-Kickback Statute makes it illegal to offer, pay, solicit, or receive anything of value to induce or reward referrals for services covered by federal healthcare programs. During diligence, buyers will review referral patterns, compensation arrangements, lease agreements, medical director contracts, and any other relationships that could raise regulatory questions. Arrangements that were set up informally or haven't been reviewed for compliance in years can create significant problems during diligence. Getting ahead of these issues before going to market is far less costly than discovering them under a buyer's microscope.
8. ​Will my licenses and accreditations transfer with the business?
It depends on how the transaction is structured and what your state requires. In an asset sale, some licenses transfer automatically while others require new applications, inspections, or approval periods that can take weeks or months. Accreditations from organizations like the Joint Commission, ACHC, or CHAP may need to be reassigned or re-surveyed. Medicare and Medicaid provider numbers often require a CHOW filing or, in some cases, a new enrollment. Provider credentialing with commercial payors may also need to be updated. These are diligence items that need to be mapped early, because a license or accreditation that can't transfer on the buyer's timeline can delay or restructure the deal.
9. What if my practice depends on one or two key providers?
This is one of the highest-risk factors a buyer can encounter. In healthcare, the risk goes beyond losing a relationship. If a key provider leaves and that provider's credentials are what allow the business to bill certain payors, the revenue impact can be immediate and significant. Buyers will evaluate employment agreements, non-compete and non-solicitation provisions, compensation structures, provider productivity, patient volume by provider, and what retention mechanisms are in place. They'll also assess whether those non-competes are enforceable in your state, since enforceability varies and some states have recently restricted physician non-competes. Building clinical depth and reducing single-provider dependency before going to market can meaningfully improve both the valuation and the deal structure.
10. How do quality ratings and clinical outcomes affect value?
Increasingly, they matter. In home health and hospice, CMS star ratings are publicly reported and directly affect referral patterns, payor relationships, and competitive positioning. In behavioral health and therapy, buyers may look at treatment completion rates, patient retention, and referral source satisfaction. In dental and physician practices, patient satisfaction scores and clinical outcomes data help buyers assess revenue sustainability and the strength of the referral network. Strong, measurable quality data supports the company's reputation and gives buyers confidence in the earnings story. Weak or undocumented quality data doesn't necessarily kill a deal, but it makes the buyer work harder to justify the valuation, and that uncertainty usually gets priced in.
11. How long will I need to stay after the sale?
Healthcare transitions tend to run longer than other industries. Credentialing updates, CHOW processing, referral relationship transfers, patient continuity requirements, and staff adjustment all take time. Buyers typically want the seller involved for 6 to 24 months post-closing, depending on the size of the business, the owner's clinical involvement, and how dependent the operation is on the founder. If you're a practicing clinician and a significant share of the patient volume is yours, expect the buyer to build a longer transition period and potentially tie a portion of the consideration to your continued involvement. Reducing that dependency before going to market shortens the required transition and gives you more flexibility in how the deal is structured.
​
​
You only sell your business once. Make it count!
Healthcare transactions carry more regulatory, licensing, and reimbursement complexity than almost any other industry. The earlier those factors are identified and addressed, the more options you have and the fewer surprises show up when a buyer starts digging.
​
If you're thinking about a sale in the next few years, a confidential conversation now costs nothing and changes nothing. It just gives you a clearer picture of where you stand.
